During the
forecast period from 2012-2022, the growth of the UC market will be driven
largely by the entry of Johnson & Johnson's (J&J's) Simponi and
Takeda's Entyvio, which will lead to an increase in the overall number of patients
being treated with biologics in the US, 5EU, Japan, and Canada.
Another key
event affecting the UC market is the anticipated launch of biosimilars, given
that the patent expiry of the UC blockbusters, Remicade and Humira are set to
expire in the US in 2018 and 2016, respectively.
Read Complete Report with TOC @ http://www.radiantinsights.com/research/kappaproct-ulcerative-colitis-forecast-and-market-analysis-to-2022
InDeX
Pharmaceuticals is a biopharmaceutical company that focuses on the discovery
and development of immunological treatments for diseases with a high unmet
need. The company is dedicated to developing personalized treatments and
diagnostic assays that will allow physicians to predict which patient
populations will respond to specific biologics. InDeX developed Kappaproct with
the goal of addressing a significant unmet need in severe UC patients, which is
the lack of an effective treatment.
Scope
- Overview
of Ulcerative Colitis, including epidemiology, etiology, symptoms, diagnosis,
pathology and treatment guidelines as well as an overview on the competitive
landscape.
- Detailed
information on Kappaproct including product description, safety and efficacy
profiles as well as a SWOT analysis.
- Sales
forecast for Kappaproct for the top five countries from 2012 to 2022.
- Sales
information covered for France, Germany, Italy, Spain and the UK.
Reasons to buy
- Understand
and capitalize by identifying products that are most likely to ensure a robust
return
- Stay ahead
of the competition by understanding the changing competitive landscape for
Ulcerative Colitis
-
Effectively plan your M&A and partnership strategies by identifying drugs
with the most promising sales potential
- Make more
informed business decisions from insightful and in-depth analysis of Kappaproct
performance
- Obtain
sales forecast for Kappaproct from 2012-2022 in the top five countries (France,
Germany, Italy, Spain and the UK)
About Us
Radiant Insights is a platform for companies
looking to meet their market research and business intelligence requirements.
We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive
collection of reports, covering over 40 key industries and a host of micro
markets. In addition to over extensive database of reports, our experienced
research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
For more
information visit: Radiant Insights
Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com
Blog
URL: http://www.esorics2010.org/
No comments:
Post a Comment